SINTX Technologies Announces Second Quarter 2026 Earnings Release Date and Webcast

SINTX Technologies (NASDAQ: SINT) will release its second quarter 2026 financial results on Tuesday, August 11, 2026, after the market close, and host a conference call and webcast at 4:30 p.m. ET to review quarterly performance.

Rhea-AI Summary

SINTX Technologies (NASDAQ: SINT) will release its second quarter 2026 financial results on Tuesday, August 11, 2026, after the market close, and host a conference call and webcast at 4:30 p.m. ET to review quarterly performance.

The call will feature CEO and Chairman Eric Olson and CFO Kevin Trask. Investors can join via a live webcast on the company’s investor relations site or by telephone after advance registration. A replay will be available on the Events & Webcasts page.

Argus Jul 28 session 2 alerts

+0.65% close to close 0.6x rel. volume Open Argus

Details

News Market Reaction – SINT

-9.2% Trough Tracked

$9.41M Market Cap

In the Jul 28 session, SINT gained 0.65%, reflecting a mild positive market reaction. Argus tracked a trough of -9.2% from its starting point during tracking. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

Historical reactions included -5.69% after June 22 purchase orders and 7.69% after the June 3 privat...

Analysis

Historical reactions included -5.69% after June 22 purchase orders and 7.69% after the June 3 private placement. This notice adds timing only; the active S-3 is a resale registration, and the scheduled results provide the next substantive company update.

Key Figures

Reporting period: Q2 2026 Release date: August 11, 2026 Webcast time: 4:30 p.m. ET

Reporting period

Q2 2026

Financial results to be released

Release date

August 11, 2026

After the market close

Webcast time

4:30 p.m. ET

Conference call and webcast on August 11, 2026

Historical Context

5 past events · Latest: Jul 23

5 events

1. Jul 23

   Strategic program

   24h Move

   -2.6%

   Engaged consultant to manage strategic partnerships, investments, acquisitions, and other opportunities

2. Jun 22

   Purchase orders

   24h Move

   -5.7%

   Received more than $3.2 million in contract manufacturing orders from existing customers

3. Jun 03

   Private placement

   24h Move

   +7.7%

   Raised approximately $5.0 million through private placement and recent ATM equity sales

4. May 17

   Investor conference

   24h Move

   +0.0%

   Scheduled presentation covering commercialization, product development, and manufacturing initiatives

5. Mar 23

   Corporate update

   24h Move

   +2.4%

   Reported first human implant, capital raise, strategic transformation, and commercialization milestones

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

silicon nitride, biomaterials, fda-cleared

3 terms

silicon nitride technical

"advanced silicon nitride ceramics and advanced material technologies"

A very hard, lightweight ceramic material made from silicon and nitrogen that resists heat, wear and corrosion. Think of it as industrial-grade pottery that can take extreme conditions where metals or plastics would fail. For investors, its use in high-performance bearings, engine parts, electronics and medical implants can signal exposure to premium, durable products, specialized manufacturing margins and markets with long-term replacement cycles.

biomaterials medical

"silicon nitride biomaterials, composites, devices, and related technologies"

Materials engineered to interact safely and effectively with living tissue—such as plastics, metals, ceramics or natural substances used for implants, wound dressings, or drug carriers. They matter to investors because their safety, durability and regulatory approval determine whether a medical product can be sold and reimbursed; think of biomaterials as the “building materials” for medical devices and therapies, where quality and certification drive market value and risk.

fda-cleared regulatory

"the FDA-cleared SINAPTIC® Foot & Ankle Implant System"

FDA-cleared means a medical product—typically a device or diagnostic—has passed a U.S. regulator’s review showing it is substantially similar to an existing approved product and is safe and effective for its intended use. For investors, clearance acts like an official safety stamp that lowers regulatory risk and can speed market access, comparable to getting a trusted roadworthy certificate before selling cars, which can make sales and adoption happen faster.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SALT LAKE CITY, Utah, July 28, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a leader in advanced silicon nitride ceramics and advanced material technologies, today announced that it will release its second quarter 2026 financial results on Tuesday, August 11, 2026, after the market close. The Company will also host a conference call and webcast that day at 4:30 p.m. ET to review the Company’s second quarter 2026 performance. Management participants will include Eric Olson, Chief Executive Officer and Chairman of the Board, and Kevin Trask, Chief Financial Officer.

Interested parties may access the conference call and webcast as follows:

Webcast: The live webcast will be available on the Events & Webcasts page of the Company’s investor relations website at ir.sintx.com and may also be accessed directly here.

Telephone: Participants who wish to join by telephone should register in advance using the Conference Call Registration link. Upon registration, participants will receive the dial-in information and a unique PIN.

A replay of the webcast will be available following the call on the Events & Webcasts page of the Company’s investor relations website.

For more information on SINTX Technologies or its biomaterial platforms, visit www.sintx.com.

About SINTX

Headquartered in Salt Lake City, Utah, SINTX Technologies, Inc. (NASDAQ: SINT) is an advanced ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. SINTX’s technologies are supported by peer-reviewed research, a patent portfolio, U.S.-based manufacturing capabilities and strategic industry relationships. The Company’s business includes proprietary biomaterials and medical device technologies, as well as contract manufacturing and other advanced ceramics opportunities. SINTX’s product portfolio includes the FDA-cleared SINAPTIC^® Foot & Ankle Implant System for reconstructive surgery.

SINTX Contacts:

Investor Relations
P: 801-839-3502
E: IR@sintx.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will SINTX Technologies (NASDAQ: SINT) report its Q2 2026 earnings?

SINTX Technologies will release its second quarter 2026 financial results on Tuesday, August 11, 2026, after the market close. According to SINTX, the earnings announcement will be followed by a conference call and webcast at 4:30 p.m. ET to review performance.

How can investors access the SINTX (SINT) Q2 2026 earnings webcast on August 11, 2026?

Investors can access the SINTX Q2 2026 earnings webcast via the Events & Webcasts page on the company’s investor relations website at ir.sintx.com. According to SINTX, a replay of the webcast will also be available on the same page after the call.

How do I register for the SINTX Technologies (SINT) Q2 2026 earnings conference call by phone?

To join the SINTX Q2 2026 earnings call by telephone, participants must register in advance using the company’s Conference Call Registration link. According to SINTX, registrants will receive dial-in details and a unique PIN needed to access the live call.

Who will speak on the SINTX (NASDAQ: SINT) Q2 2026 earnings call on August 11, 2026?

The SINTX Q2 2026 earnings call will feature Eric Olson, Chief Executive Officer and Chairman of the Board, and Kevin Trask, Chief Financial Officer. According to SINTX, they will review second quarter 2026 performance during the 4:30 p.m. ET webcast.

Where can I find the replay of the SINTX Technologies Q2 2026 earnings webcast?

A replay of the SINTX Q2 2026 earnings webcast will be available on the Events & Webcasts page of the company’s investor relations website. According to SINTX, investors can access the replay online after the live August 11, 2026 call concludes.

What does SINTX Technologies (SINT) do as an advanced ceramics company?

SINTX Technologies is an advanced ceramics company focused on developing, manufacturing, and commercializing silicon nitride biomaterials, composites, devices, and related technologies. According to SINTX, its business spans proprietary biomaterials, medical device technologies, contract manufacturing, and other advanced ceramics for medical and high-value applications.

What is SINTX Technologies’ SINAPTIC Foot & Ankle Implant System mentioned in its Q2 2026 earnings release notice?

The SINAPTIC Foot & Ankle Implant System is an FDA-cleared product used for reconstructive surgery in foot and ankle procedures. According to SINTX, it forms part of the company’s broader portfolio of silicon nitride-based biomaterials and medical device technologies for specialized clinical applications.